|
|
US 7,514,583 B2 |
|
| Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease,
type 2 diabetes, and parkinson's disease |
| Alan D. Snow, Lynnwood, Wash. (US); Beth P. Nguyen, Bothell, Wash. (US); Gerardo M. Castillo, Seattle, Wash. (US); Virginia J. Sanders, Seattle, Wash. (US); Thomas P. Lake, Snohomish, Wash. (US); Lesley Larsen, Dundein (New Zealand); Rex T. Weavers, Dundein (New Zealand); Stephen D. Lorimer, Dundein (New Zealand); David S. Larsen, Dundein (New Zealand); and David L. Coffen, San Diego, Calif. (US); Charlotte Coffen, legal representative |
| Assigned to Proteotech, Inc., Kirkland, Wash. (US) |
| Filed on May 30, 2003, as Appl. No. 10/452,851. |
| Claims priority of provisional application 60/463104, filed on Apr. 14, 2003. |
| Claims priority of provisional application 60/435880, filed on Dec. 20, 2002. |
| Claims priority of provisional application 60/412272, filed on Sep. 20, 2002. |
| Claims priority of provisional application 60/409100, filed on Sep. 09, 2002. |
| Claims priority of provisional application 60/385144, filed on May 31, 2002. |
| Prior Publication US 2004/0127555 A1, Jul. 01, 2004 |
| Int. Cl. C07C 233/75 (2006.01); A61K 31/165 (2006.01)
|